Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sad headline from The Hill news
Fauci alarmed that cases are now 16 times too high to end pandemic
Fear, uncertainty, and doubt are rampant. I will have to admit I find myself hoping sometimes when I was waiting last month. Aviptadil shortens hospital stays and frees up more beds and it is safe. That is enough to eventually get approval
Bought thousands more at .17!!!! Fire sale
Agree VF. Bad acting. Great science and he and his family own almost half the shares of NRX so I believe our money is safe. NRXP will crash and have a hard time recovering without Rlf-100 or Zyesami
Ask him on this board. Maybe a private reply. A lot of people have their reasons. I ran to Overton Brooks and got moderna. 2nd one felt like my best friend scored a 10 in arm frogging
No direct knowledge but with a solid 2 week uphill battle for both of them, I would guess not
Nope. He's late...ain't feeling too good
Dr Joey Johnson will explain it to you in more detail, later. Log into utube and look him up and be sure to subscribe! Glad you and your woman are better, Joey!
If it was real, the other board members would have asked Dr Javitt to resign and instituted damage control. Pure speculation but the only thing that makes any sense. Cardinal Health picked up Zyesami distribution. Biggest clue here. Google Cardinal Health. They don't play with small time stuff
SMOKE AND MIRRORS. Who knows why
Re rollup. We are kinda in the dark here. All that is needed is a clear, convincing reason for this public flap which they will have
As long as we are guessing...I am guessing that we may or may not receive EUA today or tomorrow but either way, RAM and Dr Javitt will be the best of partners Monday. I feel like this was a shady but legal orchestrated shake out for the purpose of aquiring more shares. This would never have been aired in public and if there are real improprieties, Dr Javitt would have been forced to step down as soon as board/large investors found out.
Let's take a breath and look this over. There might be someone somewhere better for this job than Dr Javitt but GEM is betting quite a bit on him as evidenced by GEM contacting him and getting him on board a while back and since that time Dr J and his staff has done some incredible things with rlf-100. I will go out on a large limb and tell you that he has more shares than anyone reading this and is more intelligent than all but the high level geniuses here. You will get all of your money back in a short time and it is just around the bend unless you sell. Up to you. I am knee deep in RLF stock and like everyone else, it is red. I will have a lot of money very soon, I have no doubt!
Whatever the real story behind this is one thing is certain; the only reason possible for the motivation behind this is that there is a lot of value on the table ready to be served up. It is evident to me that these companies are looking at a very positive outcome
This is a legal orchestrated hammer job so that GEM and Black Rock can finish loading up before approval next week...maybe
But that is ONLY if it affects Zyesami going to market. Perhaps the powers that be already knows we are getting approval and Javitt is wrestling for the right to market BriLife vac which looks like is contrary to their agreement. Just a hunch
Exactly what I'm thinking but it skirts the edge of criminal behaviour given the pandemic and so, we must be mistaken and this has a completely different meaning
Meanwhile...CNN latest...US reaches 40 million recorded Covid-19 cases -- with 4 million counted in the last 4 weeks
Ouch! We are sitting on a gold mine with pins in it! Staying long and strong. I believe it will happen soon
Several studies have these same findings. I believe that the intravenous version will ultimately be used more prevalently.
https://m.republicworld.com/lifestyle/health/coronavirus-not-respiratory-disease-but-vascular-illness-claims-uc-san-diego-study.html
Most of the time it is by FDA suggestion from what I read so let's wait some more
EU takes US off safe travel list; backs travel restrictions
Thanks for sharing, PW. We're closer than ever. Everything is coming up roses!
I don't believe some of you longs appreciate the entry of Cardinal Health into NRXP's PR. This health system has over 100,000 locations world wide and is the 14th largest revenue generator in the US alone! They only play with big boys
Vaccines are needed to help stop the spread and mitigate severity but this will never go away. From here on out you will be glad to hear that you have the flue. Effective therapeutics are very much needed and will get into our supply chain after FDA has finished work getting the vacs out of the way...which it appears that they have and so now, on to Aviptadil/Zyesami and $$$
Definately time to buy
We are selling under the SIX market for RLF! Great for new comers. I guess we have to shake out the fraidy cats so it can ramp up this week!!
Sure seems like the right thing to do with the BriLife success
I'm not sure about their rules but in the interest of humanity everything should be looked at and screened from the top down. If you are going to get long or make another purchase, better get to it. There are very high odds it will happen this weekend and open on the SIX Sunday night/Monday morning.
And even more positive that private venture is willing to pony up 30 million bucks! They are expecting ROI
Right JK! Guess the FEDs are going to have to rely a little more on therapeutics.
Best purchase I have ever made thanks to my alert respiratory therapist daughter that saw this a year ago in some early trials in Texas. Yes big pharma has greasier ball bearings but it was always bound to happen. NRXP did a great job getting these trials through but trying to negotiate a better deal was an after thought. They came up with the stable form so why not? It is almost time to light up that well deserved fat cigar and uncork that 21 year old scotch!
Best purchase I have ever made thanks to my alert respiratory therapist daughter that saw this a year ago in some early trials in Texas. Yes big pharma has greasier ball bearings but it was always bound to happen. NRXP did a great job getting these trials through but trying to negotiate a better deal was an after thought. They came up with the stable form so why not? It is almost time to light up that well deserved fat cigar and uncork that 21 year old scotch!
Calm yourselves. It is a good thing to shake out nervous investors!
Briefed down by Poster on Y0who...no litigation is expected. Jostling for position and that's all.
Wong2 hours ago
Just finished listening to the NRX Q2 review. Here are some notes. Some we knew and some we didn’t. Hope this helps some of you investors out there.
1. Without controls for location or severity Zyesami patients saw a 2x improvement in survival and recovery.
2. Submitted for peer review.
3. 6 fold difference in survival and recovery in tertiary hospitals mirrored the open label 45 patient study.
4. 140 patients enrolled in NIH trial to date with DSMB reporting no safety concerns.
5. Inhalant trial in Non-ICU patients results by end of 2021.
6. Expects EUA decision in coming weeks and is confident.
7. Cardinal Health will be able to deliver drug anywhere in the US within 24 hours.
8. EUA in Georgia with expansion in neighboring areas expected.
9. Zyesami is special in that it can be used in tandem with other drugs.
10. HFNC patients did better than Vented. Tertiary Vented did better than regional.
11. Everybody on drug had 5 fold lower cytokine regardless of severity or location.
12. Inhalant version and IV version expected to treat different populations based on severity.
13. Some hospitals are requesting to use Zyesami through the vent. Unknown if this will work but if it does it would be a huge breakthrough.
14. Still engaging with the FDA to support the EUA application. Confident that trial results are enough to obtain EUA.
15. No timeline exists for EUA review. Feels FDA is moving “uncharacteristically quickly”
16. National physicians society in Georgia reviewed trial results and recommended treatment to prime minister and minister of health in favor of EUA
17. Other medical societies around the globe have requested data for their own independent review.
18. Zyesami does not use buffers in manufacturing of the drug. NRX believes this will lead to data exclusivity and new IP.
19. TFFP and Mankind working towards stable room temperature powder formulation with long term patent protection.
20. Per the collaboration agreement NRX believes Relief has the right to share profits if it funds the development of Zyesami and is working towards a mutually agreeable business relationship going forward
NRXP is getting this pushed through FDA which will open up most of the rest of the world. They are jockeying for more profits which may or may not work for them but there are possibly 10 billion in profits up for grabs and everyone in this is going to be handsomely rewarded. Hook in and hold on!
The main problem is that this virus treats some people differently that others and the current treatments are not working for the severe acute respiratory failure.
Ups and downs are inevitable. This holding company is in great shape so don't listen to these experts that come out of the woodwork when they feel like being negative. Take a deep breath and look everything over.